文献速递帕金森病与运动障碍

帕金森病基因治疗:临床试验与技术进展

Gene therapy for Parkinson's disease: trials and technical advances.
PubMed 文献 · Lancet Neurol · 2025-01-01

本文综述帕金森病基因治疗的临床试验与技术进展。不同策略旨在纠正功能失调环路或保护易损神经元以延缓疾病进展。临床试验通过立体定向注射将病毒载体直接递送至脑区,或经枕大池脑脊液输注实现全局递送。GAD基因双侧递送至丘脑底核及多巴胺合成酶基因递送至壳核均带来一定临床改善;生长因子基因治疗有影像学和神经病理学证据显示基因表达和可能的神经保护;正在进行的针对GBA突变患者的基因治疗试验首次尝试纠正帕金森病的遗传病因。载体递送技术进步如新型衣壳和聚焦超声破坏血脑屏障将推动该领域发展。

要点

  • GAD基因双侧递送至丘脑底核及多巴胺合成酶基因递送至壳核均带来一定临床改善。
  • 生长因子基因治疗有影像学和神经病理学证据显示基因表达和可能的神经保护。
  • 正在进行的GBA突变患者基因治疗试验首次尝试纠正帕金森病的遗传病因。

核心结论

  • 基因治疗在帕金森病中通过纠正功能失调环路或保护易损神经元以延缓疾病进展,多种策略在临床试验中显示一定改善或可能的神经保护。

研究设计与样本

  • 综述类文章,检索范围未明确报告。

主要发现

  • GAD基因双侧递送至丘脑底核带来一定临床改善。
  • 多巴胺合成相关酶基因递送至壳核也带来一定改善。
  • 生长因子基因治疗有影像学和神经病理学证据显示基因表达和可能的神经保护。
  • 正在进行的GBA突变患者基因治疗试验首次尝试纠正帕金森病的遗传病因。

关键数值与推荐

  • 原文未报告具体标准与数值。

临床怎么用

  • 原文未报告临床实践建议。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gene therapy has long held promise as a method for targeted alteration of neuronal function in Parkinson's disease. Different gene-therapy approaches aim to correct dysfunctional circuits or have attempted to protect vulnerable neurons to slow disease progression. Clinical trials have used viral vectors to deliver genes either directly into brain regions through stereotaxic injection or globally through infusion into the CSF of the cisterna magna. Bilateral delivery of GAD into the subthalamic nucleus has resulted in some clinical improvements, and the delivery into the putamen of genes that codify for enzymes involved in dopamine synthesis has resulted also in some improvements. Growth factor gene therapy has been the focus of several studies, with both imaging and neuropathological evidence of gene expression and possible neuroprotection. An ongoing trial of gene therapy to correct mutated GBA in patients with Parkinson's disease and GBA mutations is the first to use gene therapy to try to correct a genetic cause of Parkinson's disease in human beings. Technical advancements in vector delivery, such as novel capsids and the disruption of the blood-brain barrier by use of focused ultrasound, will help advance gene therapy in Parkinson's disease.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Winston G, Kharas N, Svenningsson P, et al. Gene therapy for Parkinson's disease: trials and technical advances. Lancet Neurol. 2025. PMID: 40409318. doi:10.1016/S1474-4422(25)00125-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。